Diabetes & Wound Care
UltraMIST® therapy is a no-contact low-frequency ultrasound therapy that has been clinically proven to promote healing across a wide range of chronic and acute wounds.
No Touch Low-Frequency Ultrasound
For patients who suffer from acute or chronic wounds, any delay in healing increases the risk to patients’ overall health and quality of life. It also places a significant burden on the healthcare system. Typical wound management protocols can be successful in some cases. However, depending upon wound-specific characteristics, chronicity, and comorbidities, standard protocols leave many other patients with chronic wounds that do not heal. By choosing an energy-first approach and making UltraMIST System your first-line treatment for advanced wounds, you give your patients a high chance for improvement and, ultimately, heal their wounds.
Administered by trained healthcare personnel to thousands of patients for more than a decade and supported by a vast array of clinical evidence, the UltraMIST® System’s acoustic wave therapy promotes healing by controlling inflammation and reducing bacteria in the wound bed while increasing angiogenesis. Further, promoting healing increases perfusion through vasodilation, ultimately increasing oxygen and nutrients in the tissue.
The UltraMIST® System mechanically removes barriers and promotes healing in various wound types. Indications include, but are not limited to, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical, burn, and deep tissue injuries. It also reduces and removes many bacteria, including biofilms, while preserving healthy structures.
By activating the body’s normal regeneration process, the UltraMIST® System offers significant wound healing advantages. First, it reduces barriers to healing by reducing bacterial overgrowth, disrupting bacterial biofilms, and controlling inflammation. At the same time, UltraMIST® System therapy promotes healing through vasodilation and by accelerating angiogenesis. A meta-analysis of clinical evidence in cases including diabetic foot, ischemic, neuropathic, venous, multifactorial, pressure, surgical, and traumatic ulcers shows that wound closure increased from 24% with standard care to 42% with UltraMIST® use over a 12-week interval.
To accelerate wound healing even more, in between the UltraMIST® System treatments, other standard or advanced wound therapies may be incorporated into the treatment plan — at the discretion of the wound care professional. The result? Faster relief and better quality of life for your patients with less time and resources on costly treatments that don’t work. These savings make the UltraMIST® System a financially viable solution for the patient, the provider, and the healthcare system.
UltraMIST® achieved an 85% Area Reduction in 7 weeks across a wide range of chronic and acute wounds
Exclusive 60-Day Free Trial
Medicare reimbursement average $420 (x18 in six weeks)
Treatment days are 2 or 3 times weekly
Treatment time is 10-15 minutes (depending on size of wound)
Disposables $100 per treatment
Re-engineered for use in small medical clinics
The clinic is expected to purchase disposables during a 60-day trial
The clinic will bill insurances for payor mix review and consideration
UltraMIST's Non-Contact, Painless ultrasound technology is a safe, effective, and pain-free solution that naturally regulates inflammation, improves circulation, and stimulates tissue regeneration to drastically reduce healing time.
Call Us to Start Your Trial!
Reimbursable Foot Exam$
According to the CDC, missed opportunities to diagnose neuropathy appropriately can ultimately lead to lower-extremity amputations of the toes, feet, or legs. Properly identifying diabetic neuropathy is a serious diabetes complication that affects as many as 50% of people who suffer from pain, and another 50% who are suffering from asymptomatic/painless neuropathy - who are at the highest risk of falls, ulcerations, and amputations. One of the most underdiagnosed and untreated parts of a comprehensive foot exam is checking the loss of protective sensation (LOPS) in the feet.
The Electronic Tuning Fork™ (ETF) is a reimbursable FDA Registered Wireless Tool that Objectively Identifies and Measures Large Nerve Fibers in the Upper and Lower Extremities Painlessly.
Diabetic Large Nerve Fiber Dysfunction as Measured by Vibration Predicts Foot Ulceration, Amputation and Mortality.
Related assessment (reimbursable)
Measure Peripheral Neuropathy - Diabetic Neuropathy Device
⭐️⭐️⭐️⭐️⭐ The vibrations and temperatures are painless. -M. Brown.
Related therapy (reimbursable)
10 Preset Extremity Protocols to Reduce Pain - TENS-10 (FSA & HSA Approved)
⭐️⭐️⭐️⭐ Great little device (for minor to major pains). Lonnie P. DC
Insulin Sensitivity Supplement for Blood Sugar Support - nixulin
⭐️⭐️⭐️⭐ My numbers dropped from 305 to 163 after 3 months. -Jon J.